Validation of potential classification criteria for systemic sclerosis.
about
Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysisPrevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria.Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients.Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers.Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.Clinical and autoimmune profile of scleroderma patients from Western India.Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards.Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyClinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies.Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseSerological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium.Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based surveyDevelopment of systemic sclerosis in patients with autoimmune hepatitis: an emerging overlap syndrome.Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.Early systemic sclerosis-opportunities for treatment.Distinctions between diagnostic and classification criteria?Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration.Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.Osteomyelitis complicating scleroderma digital ulcers.Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.New ACR EULAR guidelines for systemic sclerosis classification.Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.Points to consider in renal involvement in systemic sclerosis.Validation of the ACR/EULAR classification criteria for systemic sclerosis in patients with early scleroderma.Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study.2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis
P2860
Q27000819-6C244898-9918-46F5-83C2-D0487234054DQ30658087-DE63AAE2-78C4-4F50-B9E1-EBCE09DBF07AQ33723903-9CD8F831-DAC9-4899-ACFD-6D2003B5D694Q33766384-3D71682C-32E4-4236-BF21-BB8CDB7963E1Q33834751-1F2B6FE3-DA16-4807-8D26-691DE2460BA4Q34052086-C8257CD8-5EB4-481E-93FF-3CD71151D458Q34375158-42944D3A-8F08-4449-8DD2-3AAF2D035239Q34438113-C1BCAA25-6069-462E-97A1-4E70B8539483Q34727670-E6A149CB-D5A7-4396-A6D7-2A751E8920C7Q34987366-FE1BE8E1-DDED-4B7B-820B-F5AD1A527BAEQ35140485-136AA461-4851-4568-936C-5766E8350E3EQ35784089-51CA2BFA-BD8D-4FDD-8B89-4A1C37053D73Q35948092-D9B6229D-BC10-4187-AA39-026AF2387FB9Q36664408-62546E34-D8FA-4C88-B077-DBAB2DF61727Q37080599-D092181B-99E5-4B3E-8493-D2C87A72153FQ37099395-2A38308B-5B11-4F8A-8D42-AF7D936670F4Q37579105-9099A190-D9FF-4671-BB32-C16F65C74AE9Q38019862-3D3418A8-9E6F-471A-A22D-E320687719B6Q38364855-3ED23394-EB3E-4B66-855B-CE61BDB16A4DQ38380153-2B97AFBA-7031-42E9-90F9-41EEF31CBA71Q38686272-2FB6BA21-C71B-4966-81D6-0F0BC2176BCBQ39716599-06E16EA1-12D3-4C9B-BAFE-273E14B13E1AQ40085125-28C05349-8CA5-4997-A358-E900CD05EDD6Q40234409-84F4BF88-2168-4FD0-87AC-046ACF40C8F5Q40272285-A7FFF883-44FD-4A9A-AEEA-DB20969F0589Q43240907-CC50A2CB-68D6-4A69-B457-3ED0D2394C67Q45995241-A214ABF5-DA8D-483F-9F61-3412FAD4E8C3Q48218479-ED88E248-6216-4349-8984-40EBAD7692E7Q49792212-B109F1AA-713F-4B0E-8312-E670FBF978BFQ54164380-26B0F787-6D4C-4246-B34A-86B32B8259A6Q58411438-ACDBE446-B54B-4D24-B42C-280524400697
P2860
Validation of potential classification criteria for systemic sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Validation of potential classification criteria for systemic sclerosis.
@ast
Validation of potential classification criteria for systemic sclerosis.
@en
type
label
Validation of potential classification criteria for systemic sclerosis.
@ast
Validation of potential classification criteria for systemic sclerosis.
@en
prefLabel
Validation of potential classification criteria for systemic sclerosis.
@ast
Validation of potential classification criteria for systemic sclerosis.
@en
P2093
P2860
P50
P356
P1476
Validation of potential classification criteria for systemic sclerosis.
@en
P2093
Alan Tyndall
Christine A Peschken
Dinesh Khanna
Frank van den Hoogen
Jaap Fransen
Janet E Pope
Murray Baron
Patricia E Carreira
Sindhu R Johnson
Thomas A Medsger
P2860
P304
P356
10.1002/ACR.20684
P577
2012-03-01T00:00:00Z